This Article Full Text Full Text (PDF) All Versions of this Article: 46/6/1236    most recent 01.HYP.0000193538.20705.23v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dielis, A. W.J.H. Articles by de Leeuw, P. W. Search for Related Content PubMed PubMed Citation Articles by Dielis, A. W.J.H. Articles by de Leeuw, P. W. Related Collections Other hypertension Coagulation and fibronolysis

(Hypertension. 2005;46:1236.)
© 2005 American Heart Association, Inc.

Brief Review

The Prothrombotic Paradox of Hypertension

Role of the Renin-Angiotensin and Kallikrein-Kinin Systems

Arne W.J.H. Dielis; Machiel Smid; Henri M.H. Spronk; Karly Hamulyak; Abraham A. Kroon; Hugo ten Cate; Peter W. de Leeuw

From the Department of Medicine, University Hospital Maastricht and Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands.

Correspondence to Peter W. de Leeuw, MD, PhD, FAHA, Department of Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail p.deleeuw{at}intmed.unimaas.nl

Despite increased pulsatile stress, thrombotic rather than hemorrhagic events represent a major complication of hypertension. The pathophysiology of thrombosis in hypertension involves the interaction among vascular endothelium and particularly the renin-angiotensin and kallikrein-kinin systems. Because hypertension is often associated with some degree of inflammation, the combination of chronic inflammation and chronic shear stress may convert the normal anticoagulant endothelium into a procoagulant surface, expressing tissue factor. Activation of the renin-angiotensin system leads to activation of nuclear factor B–dependent proinflammatory genes, also accelerating the expression of tissue factor. Renin-angiotensin and kallikrein-kinin systems interact at several levels to modulate coagulation, fibrinolysis, and vasodilatation in such a way that these 2 systems could have a major influence on the occurrence of thrombotic complications. Treatment with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists may favorably influence the balance between the renin-angiotensin and kallikrein-kinin axis, regulating blood pressure as well as reducing the risk of thrombosis, which may explain part of the clinical efficacy of these drugs.

Key Words: renin-angiotensin system • kallikrein-kinin systems • blood pressure

This article has been cited by other articles:

				M. Masoud, G. Sarig, B. Brenner, and G. Jacob Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System Hypertension, June 1, 2008; 51(6): 1545 - 1551. [Abstract] [Full Text] [PDF]